CYP1B1 expression in human lung

Drug Metabolism and Disposition

Volumn 29, Issue 6, 2001, Pages 916-922

  Spivack, Simon D ^a   Hurteau, Gregory J ^a   Reilly, Andrew A ^a   Aldous, Kenneth M ^a   Ding, Xinxin ^a   Kaminsky, Laurence S ^a  

^a WADSWORTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN; CYTOCHROME P450 1B1;

ARTICLE; ENZYME ACTIVITY; ENZYME LOCALIZATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; SMOKING;

ARYL HYDROCARBON HYDROXYLASES; BASE SEQUENCE; CARCINOMA, NON-SMALL-CELL LUNG; CYTOCHROME P-450 ENZYME SYSTEM; DNA PRIMERS; FEMALE; HUMANS; LUNG; LUNG NEOPLASMS; MALE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUBERCULOSIS;

EID: 0035006986     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Agresti A (1992) A survey of exact inference contingency tables. Stat Sci 7:131-153.
2. Agundez JAG, Martinez C, Ladero JM, Ledesma MC, Ramos JM, Martin R, Rodruguez A, Jara C and Benitez J (1994) Debrisoquine oxidative genotype and susceptibility to lung cancer. Clin Pharmacol Ther 55:10-14.
3. Bishop YMM, Fienberg SE and Holland PW (1975) Discrete Multivariate Analysis: Theory and Practice, pp 165-168, MIT Press, Cambridge, MA.
4. Bouchardy C, Benhamou S and Dayer P (1996) The effect of tobacco on lung cancer risk depends on CYP2D6 activity. Cancer Res 56:251-253.
5. Christou M, Savas U, Schroeder S, Shen X, Thompson T, Gould MN and Jefcoate CR (1995) Cytochromes CYP1A1 and CYP1B1 in the rat mammary gland: cell-specific expression and regulation by polyaromatic hydrocarbons and hormones. Mol Cell Endocrinol 115:41-50.
6. Cox DR (1970) The Analysis of Binary Data, pp 87-94, Methuen & Co. Ltd., London.
7. Davis RA (1986) The determination of nicotine and cotinine in plasma J Chromatogr Sci 24:134-141.
8. Drakoulis N, Cascorbi I, Brockmoller J, Groos CR and Roots I (1994) Polymorphisms in the human CYP1A1 gene as a susceptibility factor for lung cancer. Clin Invest 72:240-248.
9. Eltom SE, Zhang L and Jefcoate CR (1999) Regulation of cytochrome P450 1B1 in mouse hepa-1 variant cell lines: a possible role for aryl hydrocarbon receptor nuclear translocator (ARNT) as a suppressor of CYP1B1 gene expression. Mol Pharmacol 55:594-604.
10. Ernster VL (1994) The epidemiology of lung cancer in women. Ann Epidemiol 4:102-110.
11. Fasco MJ, Silkworth JB, Dunbar DA and Kaminsky LS (1993) Rat small intestinal cytochromes P450 probed by warfarin metabolism. Mol Pharmacol 43:226-233.
12. Hukkola J, Pasanen M, Pelkonen O, Hukkamem J, Evisalmi S, Anttila S, Rane A, Mantyla M, Purkunen R, Saarikoski S, et al. (1997) Expression of CYP1B1 in human adult and fetal tissues and differential inducibility of CYP1B1 and CYP1A1 by Ah receptor ligands in human placental and cultured cells. Carcinogenesis 18:391-397.
13. Hamada GS, Sugimura H, Suzuki I, Nagura K, Kiyokawa B, Iwase T, Tanaka M, Takahashi T, Watanabe S and Kino I (1995) The heme-binding region of CYP1A1, rather than the Rsa polymorphism of CYP2E1, is associated with lung cancer in Rio de Janeiro. Cancer Epidemiol Biomarkers Prev 4:63-67.
14. Hayes CL, Spink DC, Spink BC, Cao JQ, Walker NJ and Sutter TR (1996) 17β-Estradiol hydroxylation catalyzed by human cytochrome P4501B1. Proc Natl Acad Sci USA 93:9776-9781.
15. Hirvonen A, Husgafvel-Pursiainen K, Anttilo S, Karjalainen A and Vainio H (1993) The human CYP2E1 gene and lung cancer: DraI and RsaI restriction fragment length polymorphisms in a Finnish study population. Carcinogenesis 14:85-88.
16. Hirvonen A, Husgufvel-Pursiainen K, Karjalainen A, Anttila S and Vainio H (1992) Point-mutational Mspl and Ile-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epideemiol Biomarkers Prev 1:485-489.
17. Huang Z, Fasco MJ and Kaminsky LS (1996) Optimization of Dnase I removal of contaminating DNA from RNA for use in quantitative RNA-PCR. Biotechniques 20:1012-1020.
18. Kato S, Shields PG, Caporaso NE, Hoover RN, Trump BF, Sugimura H, Weston A and Harris CC (1992) Cytochrome P4502E1 genetic polymorphisms, racial variation and lung cancer risk. Cancer Res 52:6712-6715.
19. Kim JH, Stansbury KH, Walker NJ, Trush MA, Strickland PT and Sutter TR (1998) Metabolism of benzo[a]pyrene and benzo[a]pyrene-7,8-diol by human cytochrome P450 1B1. Carcinogenesis 19:1847-1853.
20. Li JJ and Li SA (1987) Estrogen carcinogenesis in Syrian hamster tissues: role of metabolism. Fed Proc 46:1858-1863.
21. Liehr JG, Fang WF, Sirbasku DA and Ari-Ulubelen A (1986) Carcinogenicity of catechol estrogens in the Syrian hamster. J Steroid Biochem 24:353-356.
22. McFayden MCE, Breeman S, Payne S, Stirk C, Miller ID, Melvin WT and Murray GI (1999) Immunohistochemical localisation of cytochrome P450 CYP1B1 in breast cancer with monoclonal antibodies specific for CYP1B1. J Histochem Cytochem 47:1457-1464.
23. Murray GI, Taylor MC, McFayden MCE, McKay JA, Greenlee WF, Burke MD and Melvin WT (1997) Tumor-specific expression of cytchrome P450 CYP1B1 Cancer Res 57:3026-3031.
24. Rowlands JC and Gustafsson J-A (1997) Aryl hydrocarbon receptor-mediated transduction. Crit Rev Toxicol 27(2):109-134.
25. Ryberg D, Hewer A, Phillips DH and Haugen A (1994) Different susceptibility to smoking-induced DNA damage among male and female lung cancer patients. Cancer Res 54:5801-5803.
26. Seber GAF (1997) Linear Regression Analysis, pp 126, John Wiley & Sons, New York.
27. Shaw GL, Falk RT, Deslauriers J, Frame JN, Nesbitt JC, Pass HI, Issaq HJ, Hoover RN and Tucker MA (1995) Debrisoquine metabolism and lung cancer. Cancer Epidemiol Biomarkers Prev 4:41-48.
28. Shields PG, Caporaso NE, Falk RT, Sugimura H, Trivers GE, Trump BF, Hoover RN, Weston A and Harris CC (1993) Lung cancer, race, and a CYP1A1 genetic polymorphism. Cancer Epidemiol Biomarkers Prev 1:481-485.
29. Shimada T, Hayes CL, Yamazaki H, Amin S, Hecht SS, Guengerich FP and Sutter TR (1996) Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Res 56:2979-2984.
30. Spink BC, Fasco MJ, Gierthy JF and Spink DC (1998a) 12-O-Tetradecanoylphorbol-13-acetate upregulates the Ah receptor and differentially alters CYP1B1 and CYP1A1 expression in MCF-7 breast cancer cells. J Cell Biocchem 70:289-296.
31. Spink DC, Spink BC, Cao JQ, DePasquale JA, Pentecost BT, Fasco MJ, Li Y and Sutter TR (1998b) Differential expression of CYP1A1 and CYP1B1 in human breast epithelial cells and breast tumor cells. Carcinogenesis 19:291-298.
32. Spivack SD, Fasco MJ, Walker VE and Kaminsky LS (1997) The molecular epidemiology of lung cancer. Crit Rev Toxicol 27:319-365.
33. Sugimura H, Sumki I, Hamada GS, Iwise T, Takahishi T, Nagura K, Iwata H, Watanabe S, Kino I and Tsugane S (1994) Cytochrome P450 1A1 genotype in lung cancer patients and controls in Rio de Janeiro, Brazil. Cancer Epidemiol Biomarkers Prev 3:145-148.
34. Sutter TR, Tang TM, Hayes CL, Wo Y-YP, Jabs EW, Li X, Yin H, Cody CW and Greenlee WF (1994) Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. J Biol Chem 269:13092-13099.
35. Tang YM, Chen G-F, Thompson PA, Lin D-X, Lang NP and Kadlubar FF (1999) Development of an antipeptide antibody that binds to the C-terminal region of human CYP1B1 Drug Metab Dispos 27:274-280.
36. Whitlock JP, Okino ST, Dong L, Ko HP, Clarke-Katzenberg R, Ma Q and Li H (1996) Induction of cytochrome P4501A1: a model for analyzing mammalian gene transcription. FASEB J 10:809-818.
37. Willey JC, Coy EL, Frampton MW, Torres A, Apostolakos MJ, Hoehn G, Schuermann WH, Thilly WG, Olson DE, Hammersley JR, et al. (1997) Quantitative RT-PCR measurement of cytochromes P450 1A1, 1B1, and 2B7, microsomal epoxide hydrolase, and NADPH oxi-doreductase expression in lung cells of smokers and nonsmokers. Am J Respir Cell Mol Biol 17:114-124.
38. Zang EA and Wynder EL (1996) Differences in lung cancer risk between men and women: examination of the evidence. J Natl Cancer Inst 88:183-192.